Target intelligence / Profile preview

RNA, 5S ribosomal pseudogene 212 (RNA5SP212)

Target
RNA5SP212
Molecular classification
Pseudogene, rRNA pseudogene, Non-coding RNA pseudogene, Processed pseudogene
01

Overview

RNA, 5S ribosomal pseudogene 212 (RNA5SP212) is a processed pseudogene of the 5S ribosomal RNA gene[2][4][8]. Pseudogenes are genomic DNA sequences resembling functional genes, but typically carry mutations or truncations rendering them nonfunctional—they do not produce functional proteins or RNAs[8][2][6]. The 5S rRNA gene normally encodes a small, highly conserved component of the ribosome essential for protein synthesis, but pseudogenes derived from this gene—such as RNA5SP212—are non-functional relics that retain high sequence similarity yet lack coding capability or defined cellular function[4][8]. As a result, they are not considered valid molecular targets for therapeutics or biomarkers, and their presence is primarily of interest for genome annotation and evolutionary studies, not for disease or pharmacological intervention[2][4][8]. Note on correctness: This is not a canonical drug or receptor target, but a pseudo-gene annotation. The use of “RNA5SP212” as a drug/receptor/therapeutic target is incorrect[4][2][8].

Other names
RN5S212RNA, 5S ribosomal 2125S rRNA pseudogene 212
02

Mechanism of action

None

03

Biological functions

No independent biological function; non-coding segment of DNA resembling 5S ribosomal RNA gene
04

Disease associations

None currently established; pseudogenes are sometimes involved in regulatory functions but no disease association is known for RNA5SP212 specifically

Beyond the preview

Go deeper on RNA, 5S ribosomal pseudogene 212 (RNA5SP212).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 5S ribosomal pseudogene 212 (RNA5SP212).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call